FASS logotyp

Peka på symbolerna och beteckningarna till vänster för en förklaring.

Kontakt

Orfiril

Desitin

Enterotablett 600 mg
Avregistreringsdatum: 2003-02-28 (Tillhandahålls ej)

Aktiv substans:
ATC-kod: N03AG01
För information om det avregistrerade läkemedlet omfattas av Läkemedelsförsäkringen, kontakta Läkemedelsförsäkringen.
Läs mer om avregistrerade läkemedel

Miljöinformation

Miljöpåverkan

Miljöinformationen för valproinsyra är framtagen av företaget Sanofi AB för Ergenyl, Ergenyl Retard

Miljörisk: Användning av valproinsyra har bedömts medföra försumbar risk för miljöpåverkan.
Nedbrytning: Valproinsyra är potentiellt persistent.
Bioackumulering: Valproinsyra har låg potential att bioackumuleras.


Läs mer

Detaljerad miljöinformation

Environmental Risk Classification

Predicted Environmental Concentration (PEC)

PEC is calculated according to the following formula:

PEC (µg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.5*10-6*A*(100-R)


PEC = 0.245 µg/L


Where:

A = 1636.091 kg (total sold amount API in Sweden year 2019, data from IQVIA)

R = 0% removal rate (due to loss by adsorption to sludge particles, by volatilization, hydrolysis or biodegradation)

P = number of inhabitants in Sweden = 9*106

V (l/day) = volume of wastewater per capita and day = 200 (ECHA default) (Ref I)

D = factor of dilution of waste water by surface water flow = 10 (ECHA default) (Ref I)


Predicted No Effect Concentration (PNEC)

Ecotoxicological studies

Algae (Pseudokirchneriella subcapitata):

EC50 72 h (biomass) = >100 000 µg/L

EC50 72 h (growth rate) = >100 000 µg/L

NOEC = 100 000 µg/L

(OECD 201)
(Ref II)


Crustacean (Daphnia magna):

EC50 48 h (immobilization) = >100 000 µg/L

NOEC 48 h (immobilization) = >100 000 µg/L

(OECD 202)
(Ref III)

Chronic toxicity crustacean (Daphnia magna)

NOEC, EC50, EC10 21 d (reproduction) ≥ 8870 µg/L
(OECD 211)

(Ref IV)

Fish (Danio rerio):

LC50 96 h (lethality) = 66 000 µg/L

(OECD 236)
(Ref V)

Chronic toxicity fish (Danio rerio)
NOEC 30 d (mortality) ≥ 10 200 µg/L
(OECD 210)
(Ref VI)

Other ecotoxicity data:

PNEC = 887 µg/L


The PNEC is calculated with the following formula: lowest EC10 or NOEC/10 (Assessment factor justification: three long-term toxicity endpoints available for three trophic levels: algae, daphnia and fish)


EC10 for Daphnia magna has been used for this calculation since it is the most sensitive of the tested species.


Environmental Risk Classification (PEC/PNEC ratio)

PEC/PNEC = 0.245 µg/L / 887 µg/L = 0.00028, i.e. PEC/PNEC ≤ 0.1, which justifies the phrase "Use of valproic acid has been considered to result in insignificant environmental risk".


Biodegradation

Ready biodegradability:

Test showed 48 % degradation in 28 days.
(OECD 301)
(Ref VII)


Justification of chosen degradation phrase:

Valproic acid fails to pass the criteria for ready biodegradability. The phrase "Valproic acid is potentially persistent" is thus chosen.


Bioaccumulation

Partition coefficient

Log Kow = 2.60 at pH 7
(OECD 107)
(Ref VIII)


Justification of chosen bioaccumulation phrase:

Since log Kow < 4 at pH 7, valproic acid has low potential for bioaccumulation.


Excretion (metabolism)
Most drug is metabolized to glucuronide conjugates (30-50 %) of the parent drug or of metabolites. Another large portion is metabolized through mitochondrial β-oxidation (40 %). The remainder of metabolism (15-20 %) occurs through oxidation, hydroxylation, and dehydrogenation.


Most drug is eliminated through hepatic metabolism, about 30-50 %. The other major contributing pathway is mitochondrial β-oxidation, about 40 %. Other oxidative pathways make up an additional 15-20 %. Less than 3 % is excreted unchanged in the urine.

(Ref IX).


References

  1. ECHA, European Chemicals Agency, 2008 Guidance on information requirements and chemical safety assessment . https://echa.europa.eu/guidance-documents/guidance-on-information-requirements-and-chemical-safety-assessment

  2. Sanofi, Internal Report: Growth inhibition test with Sodium Valproate on Algae (Pseudokirchneriella subcapitata). OECD 201. Report # 11/157-022AL, March 2012.

  3. Sanofi, Internal Report:Acute immobilization test with Sodium Valproate on Daphnia (Daphnia magna). OECD 202. Report #11/157-023DA, March 2012

  4. ECHA, registration dossier on 2-propylvaleric acid, Long-term toxicity to aquatic invertebrates, Read across on Sodium Valproate. Available on (2021-08-24): https://echa.europa.eu/fr/registration-dossier/-/registered-dossier/14340/6/2/5

  5. Sanofi, Internal report: Sodium Valproate: Fish Embryo Acute toxicity (FET) test. OECD 236. Report # 3200886, April 2015

  6. ECHA, registration dossier on 2-propylvaleric acid, Long-term toxicity to fish, Read across on Sodium Valproate. Available on (2021-08-24): https://echa.europa.eu/fr/registration-dossier/-/registered-dossier/14340/6/2/5

  7. Sanofi, Internal Report: Determination of the ready biodegradability CO2 evolution test. OECD 301B. Report # 32153 ECS, February 2007

  8. Henczi, M., Nagy, J., Weaver, D.F., 1995. Determination of Octanol-water Partition Coefficients by an HPLC method for Anticonvulsant Structure-activity studies. Journal of Pharmacy and Pharmacology. 47, 345-347.

  9. Drug Bank - Valproic acid - retrieved from drugbank.com 2021-08-24, find here.